Seeking AlphaWed, 10 Jun 2026 00:22:12 GMTRoivant Sciences Ltd. (ROIV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptROIV+1.97%
Seeking AlphaWed, 03 Jun 2026 22:32:01 GMTRoivant Sciences Ltd. (ROIV) Presents at Jefferies Global Healthcare Conference 2026 TranscriptROIV+1.97%
Seeking AlphaFri, 29 May 2026 21:24:06 GMTRoivant Sciences Ltd. (ROIV) Presents at Bernstein 42nd Annual Strategic Decisions Conference TranscriptROIV+1.97%
Seeking AlphaThu, 21 May 2026 17:09:35 GMTRoivant: Immunovant's Rheumatoid Arthritis Win Validates The BuyROIV+1.97%
Seeking AlphaWed, 20 May 2026 22:20:55 GMTRoivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call TranscriptROIV+1.97%
BarronsWed, 20 May 2026 15:38:00 GMT2 Biotech Stocks Are Surging Today Thanks to This Arthritis DrugROIV+1.97%
Zacks Investment ResearchWed, 20 May 2026 13:15:12 GMTRoivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue EstimatesROIV+1.97%
Zacks Investment ResearchTue, 19 May 2026 17:01:16 GMTMontes Archimedes Acquisition (ROIV) Upgraded to Buy: Here's WhyROIV+1.97%
Seeking AlphaWed, 13 May 2026 20:50:45 GMTRoivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 TranscriptROIV+1.97%
Seeking AlphaWed, 29 Apr 2026 15:05:04 GMTRoivant Sciences: Moderna Settlement And Brepocitinib Support A Long-Term BuyROIV+1.97%
Zacks Investment ResearchFri, 10 Apr 2026 17:00:47 GMTMontes Archimedes Acquisition (ROIV) Upgraded to Buy: Here's What You Should KnowROIV+1.97%
Seeking AlphaThu, 02 Apr 2026 20:32:04 GMTRoivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data Update TranscriptROIV+1.97%
